These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7850406)
21. The diversified pharmacology of angiotensin II-receptor blockade. Timmermans PB; Smith RD Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541 [TBL] [Abstract][Full Text] [Related]
22. Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor. Identification of amino acid residues that determine binding of the antihypertensive drug losartan. Ji H; Leung M; Zhang Y; Catt KJ; Sandberg K J Biol Chem; 1994 Jun; 269(24):16533-6. PubMed ID: 8206967 [TBL] [Abstract][Full Text] [Related]
23. Nonpeptide angiotensin II receptor antagonists: in vivo inhibition of [125I-Sar1,Ile8]angiotensin II binding by losartan, EXP597 and L-159,282 in rats. Wong PC; Herblin WF; Barbera FA; Bernard R; Bozarth TA; Watson CA; Gibson RE Clin Exp Hypertens; 1996 Feb; 18(2):189-200. PubMed ID: 8869000 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin II receptor subtypes in cultured rat renal mesangial cells. Ernsberger P; Zhou J; Damon TH; Douglas JG Am J Physiol; 1992 Sep; 263(3 Pt 2):F411-6. PubMed ID: 1415569 [TBL] [Abstract][Full Text] [Related]
25. Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature. Zhuo J; Dean R; MacGregor D; Alcorn D; Mendelsohn FA Clin Exp Pharmacol Physiol Suppl; 1996; 3():S147-54. PubMed ID: 8993855 [TBL] [Abstract][Full Text] [Related]
26. Effects of angiotensin II and its selective antagonists on inferior olivary neurones. Ambühl P; Felix D; Imboden H; Khosla MC; Ferrario CM Regul Pept; 1992 Sep; 41(1):19-26. PubMed ID: 1333623 [TBL] [Abstract][Full Text] [Related]
27. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa. Boulay G; Servant G; Luong TT; Escher E; Guillemette G Mol Pharmacol; 1992 Apr; 41(4):809-15. PubMed ID: 1569928 [TBL] [Abstract][Full Text] [Related]
28. The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. Siragy HM; Carey RM J Clin Invest; 1996 Apr; 97(8):1978-82. PubMed ID: 8621783 [TBL] [Abstract][Full Text] [Related]
29. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat. Cox SL; Story DF; Ziogas J Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747 [TBL] [Abstract][Full Text] [Related]
30. New perspectives in angiotensin system control. Timmermans PB; Wong PC; Chiu AT; Herblin WF; Smith RD J Hum Hypertens; 1993 Aug; 7 Suppl 2():S19-31. PubMed ID: 8230085 [TBL] [Abstract][Full Text] [Related]
31. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet. Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366 [TBL] [Abstract][Full Text] [Related]
32. Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists. Regitz-Zagrosek V; Auch-Schwelk W; Hess B; Klein U; Duske E; Steffen C; Hildebrandt AG; Fleck E J Cardiovasc Pharmacol; 1995 Jul; 26(1):66-72. PubMed ID: 7564368 [TBL] [Abstract][Full Text] [Related]
33. Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy. Eberhardt RT; Kevak RM; Kang PM; Frishman WH J Clin Pharmacol; 1993 Nov; 33(11):1023-38. PubMed ID: 8300885 [TBL] [Abstract][Full Text] [Related]
34. The contribution of AT1 and AT2 angiotensin receptors to its cognitive effects. Braszko J Acta Neurobiol Exp (Wars); 1996; 56(1):49-54. PubMed ID: 8787210 [TBL] [Abstract][Full Text] [Related]
35. Distribution of angiotensin II receptor subtypes in rat brain nuclei. Obermüller N; Unger T; Culman J; Gohlke P; de Gasparo M; Bottari SP Neurosci Lett; 1991 Oct; 132(1):11-5. PubMed ID: 1787912 [TBL] [Abstract][Full Text] [Related]
36. EXP597, a nonpeptide angiotensin II receptor antagonist with high affinities for the angiotensin AT1 and AT2 receptor subtypes. Wong PC; Duncia JV; Santella JB; Smith RD; Wexler RR; Timmermans PB; Chiu AT Eur J Pharmacol; 1994 Aug; 260(2-3):261-4. PubMed ID: 7988654 [TBL] [Abstract][Full Text] [Related]
37. Angiotensin-II receptor subtypes in median eminence and basal forebrain areas involved in regulation of pituitary function. Tsutsumi K; Saavedra JM Endocrinology; 1991 Dec; 129(6):3001-8. PubMed ID: 1954884 [TBL] [Abstract][Full Text] [Related]
38. Role of angiotensin AT1 receptor in the cardiovascular response to footshock. Cierco M; Israel A Eur J Pharmacol; 1994 Jan; 251(1):103-6. PubMed ID: 8137866 [TBL] [Abstract][Full Text] [Related]
39. Binding of [3H]angiotensin II and [3H]DuP 753 (Losartan) to rat liver homogenates reveals multiple sites. Relationship to AT1a- and AT1b-type angiotensin receptors and novel nonangiotensin binding sites. Widdowson PS; Renouard A; Vilaine JP Peptides; 1993; 14(4):829-37. PubMed ID: 8234032 [TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of angiotensin-II receptor subtypes in cultured bovine and human adrenal fasciculata cells and PC12W cells. Ouali R; LeBrethon MC; Saez JM Endocrinology; 1993 Dec; 133(6):2766-72. PubMed ID: 8243303 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]